Telemedycyna Polska SA
WSE:TMP

Watchlist Manager

Telemedycyna Polska SA

WSE:TMP

Watchlist

Dividends

Price: 0.67 PLN Market Closed

Market Cap: 7.2m PLN

Activate Unlimited Plan
to continue TMP research

You've reached your weekly stock limit.

14-day money-back guarantee

Have any thoughts about
Telemedycyna Polska SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 0.67 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

TMP Alert

Telemedycyna Polska SA

0.67

0.00 (0%)

52 Week Range	0.58 1.78
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Telemedycyna Polska SA

What unique competitive advantages
does Telemedycyna Polska SA hold over its rivals?

What risks and challenges
does Telemedycyna Polska SA face in the near future?

Provide an overview of the primary business activities
of Telemedycyna Polska SA.

Show all valuation multiples
for Telemedycyna Polska SA.

Provide an overview of the primary business activities
of Telemedycyna Polska SA.

What unique competitive advantages
does Telemedycyna Polska SA hold over its rivals?

What risks and challenges
does Telemedycyna Polska SA face in the near future?

Show all valuation multiples
for Telemedycyna Polska SA.

Provide P/S
for Telemedycyna Polska SA.

Provide P/E
for Telemedycyna Polska SA.

Provide P/OCF
for Telemedycyna Polska SA.

Provide P/FCFE
for Telemedycyna Polska SA.

Provide P/B
for Telemedycyna Polska SA.

Provide EV/S
for Telemedycyna Polska SA.

Provide EV/GP
for Telemedycyna Polska SA.

Provide EV/EBITDA
for Telemedycyna Polska SA.

Provide EV/EBIT
for Telemedycyna Polska SA.

Provide EV/OCF
for Telemedycyna Polska SA.

Provide EV/FCFF
for Telemedycyna Polska SA.

Provide EV/IC
for Telemedycyna Polska SA.

Compare the intrinsic valuations
of Telemedycyna Polska SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Telemedycyna Polska SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Telemedycyna Polska SA compared to its peers.

Compare the P/E ratios
of Telemedycyna Polska SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Telemedycyna Polska SA with its peers.

Analyze the financial leverage
of Telemedycyna Polska SA compared to its main competitors.

Show all profitability ratios
for Telemedycyna Polska SA.

Provide ROE
for Telemedycyna Polska SA.

Provide ROA
for Telemedycyna Polska SA.

Provide ROIC
for Telemedycyna Polska SA.

Provide ROCE
for Telemedycyna Polska SA.

Provide Gross Margin
for Telemedycyna Polska SA.

Provide Operating Margin
for Telemedycyna Polska SA.

Provide Net Margin
for Telemedycyna Polska SA.

Provide FCF Margin
for Telemedycyna Polska SA.

Show all solvency ratios
for Telemedycyna Polska SA.

Provide D/E Ratio
for Telemedycyna Polska SA.

Provide D/A Ratio
for Telemedycyna Polska SA.

Provide Interest Coverage Ratio
for Telemedycyna Polska SA.

Provide Altman Z-Score Ratio
for Telemedycyna Polska SA.

Provide Quick Ratio
for Telemedycyna Polska SA.

Provide Current Ratio
for Telemedycyna Polska SA.

Provide Cash Ratio
for Telemedycyna Polska SA.

What is the historical Revenue growth
over the last 5 years for Telemedycyna Polska SA?

What is the historical Net Income growth
over the last 5 years for Telemedycyna Polska SA?

What is the current Free Cash Flow
of Telemedycyna Polska SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Telemedycyna Polska SA.

Relative Value Valuation Multiples Multiples Across Competitors See Also

Section:

Relative Value

Valuation Multiples

Multiples Across Competitors

Relative Value

There is not enough data to reliably calculate the relative value of TMP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Valuation FAQ:

What is Relative Valuation?

How is Relative Value calculated?

TMP Relative Value

Base Case

Not Available

Worst Case

Base Case

Best Case

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
PL	T	Telemedycyna Polska SA WSE:TMP	7.2m PLN	0	0	0	0
US	C	Cigna Group XMUN:CGN	73.6B EUR	0.3	17.2	8.5	10.9
US		Cigna Corp NYSE:CI	86.3B USD	0.3	17.1	8.4	10.8
US		CVS Health Corp NYSE:CVS	85.1B USD	0.2	16.1	13.1	13.1
DE		Fresenius Medical Care AG XMUN:FME	27.9B EUR	1.4	45.2	11.9	25.8
DE		Fresenius SE & Co KGaA XETRA:FRE	23.9B EUR	1.1	56.7	10.4	16.8
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.7	30	15.1	23.8
US		Quest Diagnostics Inc NYSE:DGX	19.8B USD	2	22.2	12.9	17.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	14B EUR	0.7	22.7	7.3	15.8
US		DaVita Inc NYSE:DVA	11B USD	0.8	12.8	7.5	10.3
US		Hims & Hers Health Inc NYSE:HIMS	10.7B USD	6	65.3	75.4	90

				Revenue Growth	P/S to Growth
PL	T	Telemedycyna Polska SA WSE:TMP	Average P/S: 1.5 Not Available	N/A	N/A
US	C	Cigna Group XMUN:CGN	0.3	6%	0.1
US		Cigna Corp NYSE:CI	0.3	6%	0.1
US		CVS Health Corp NYSE:CVS	0.2	5%	0
DE		Fresenius Medical Care AG XMUN:FME	1.4	3%	0.5
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
US		Laboratory Corporation of America Holdings NYSE:LH	1.7	7%	0.2
US		Quest Diagnostics Inc NYSE:DGX	2	6%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.7	3%	0.2
US		DaVita Inc NYSE:DVA	0.8	5%	0.2
US		Hims & Hers Health Inc NYSE:HIMS	6	33%	0.2

				Earnings Growth	PEG
PL	T	Telemedycyna Polska SA WSE:TMP	Average P/E: 30.5 Not Available	N/A	N/A
US	C	Cigna Group XMUN:CGN	17.2	43%	0.4
US		Cigna Corp NYSE:CI	17.1	43%	0.4
US		CVS Health Corp NYSE:CVS	16.1	30%	0.5
DE		Fresenius Medical Care AG XMUN:FME	45.2	37%	1.2
DE		Fresenius SE & Co KGaA XETRA:FRE	56.7	68%	0.8
US		Laboratory Corporation of America Holdings NYSE:LH	30	31%	1
US		Quest Diagnostics Inc NYSE:DGX	22.2	14%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	22.7	37%	0.6
US		DaVita Inc NYSE:DVA	12.8	6%	2.1
US		Hims & Hers Health Inc NYSE:HIMS	65.3	32%	2

				EBITDA Growth	EV/EBITDA to Growth
PL	T	Telemedycyna Polska SA WSE:TMP	Average EV/EBITDA: 17.1 Not Available	N/A	N/A
US	C	Cigna Group XMUN:CGN	8.5	4%	2.1
US		Cigna Corp NYSE:CI	8.4	4%	2.1
US		CVS Health Corp NYSE:CVS	13.1	25%	0.5
DE		Fresenius Medical Care AG XMUN:FME	11.9	11%	1.1
DE		Fresenius SE & Co KGaA XETRA:FRE	10.4	13%	0.8
US		Laboratory Corporation of America Holdings NYSE:LH	15.1	16%	0.9
US		Quest Diagnostics Inc NYSE:DGX	12.9	8%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	7.3	11%	0.7
US		DaVita Inc NYSE:DVA	7.5	4%	1.9
US		Hims & Hers Health Inc NYSE:HIMS	75.4	86%	0.9

				EBIT Growth	EV/EBIT to Growth
PL	T	Telemedycyna Polska SA WSE:TMP	Average EV/EBIT: 23.5 Not Available	N/A	N/A
US	C	Cigna Group XMUN:CGN	10.9	6%	1.8
US		Cigna Corp NYSE:CI	10.8	6%	1.8
US		CVS Health Corp NYSE:CVS	13.1	17%	0.8
DE		Fresenius Medical Care AG XMUN:FME	25.8	26%	1
DE		Fresenius SE & Co KGaA XETRA:FRE	16.8	20%	0.8
US		Laboratory Corporation of America Holdings NYSE:LH	23.8	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	17.5	12%	1.5
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	15.8	26%	0.6
US		DaVita Inc NYSE:DVA	10.3	6%	1.7
US		Hims & Hers Health Inc NYSE:HIMS	90	77%	1.2

T	Telemedycyna Polska SA WSE:TMP	0.67 PLN
	Cogeco Inc TSX:CGO	68.86 CAD 0.03%
	Bang & Olufsen A/S CSE:BO	13.1 DKK 1.24%
P	Pandora A/S CSE:PNDORA	1 085.5 DKK -1.68%
	Manulife Financial Corp TSX:MFC	42.79 CAD -0.14%
	Nomad Royalty Company Ltd TSX:NSR	9.67 CAD 1.36%

	Johnson & Johnson NYSE:JNJ	156.01 USD 0.29%
	Berkshire Hathaway Inc NYSE:BRK.A	727 455 USD 0.97%
	Bank of America Corp NYSE:BAC	48.93 USD 0.45%
	Mastercard Inc NYSE:MA	569.24 USD 1.37%
	UnitedHealth Group Inc NYSE:UNH	308.55 USD 0.32%
	Exxon Mobil Corp NYSE:XOM	112.2 USD 1.04%

	Franklin Covey Co NYSE:FC	22.1 USD -8.56%
	Mohawk Industries Inc NYSE:MHK	110.84 USD -0.4%
	Ardmore Shipping Corp NYSE:ASC	10.25 USD 0.49%
	ASGN Inc NYSE:ASGN	52.84 USD 1.23%
	Skyworks Solutions Inc NASDAQ:SWKS	78.76 USD 0.74%
	Weatherford International PLC NASDAQ:WFRD	54.15 USD -2.11%

	Monolithic Power Systems Inc NASDAQ:MPWR	758.64 USD -0.75%
	NVIDIA Corp NASDAQ:NVDA	159.34 USD 1.33%
	Pro Medicus Ltd ASX:PME	308.87 AUD 0.32%
P	Plover Bay Technologies Ltd HKEX:1523	6.01 HKD 0.33%
S	SciClone Pharmaceuticals (Holdings) Ltd HKEX:6600	18.72 HKD
	Alfa Financial Software Holdings PLC LSE:ALFA	221.5 GBX

	Salesforce Inc NYSE:CRM	272.15 USD 1.09%
	Accenture PLC NYSE:ACN	304.78 USD 0.82%
	ServiceNow Inc NYSE:NOW	1 044.69 USD 3.46%
	Spotify Technology SA NYSE:SPOT	725.05 USD 2.19%
	EOG Resources Inc NYSE:EOG	123.15 USD 0.22%
	Monster Beverage Corp NASDAQ:MNST	63.08 USD 0.06%

vs History
vs Industry

vs History
vs Industry

vs History
vs Industry

vs History
vs Industry

Telemedycyna Polska SA WSE:TMP

Relative Value

Valuation Multiples

Multiples Across Competitors

TMP Competitors Multiples Telemedycyna Polska SA Competitors

See Also

Company

Help

Tools

Stocks

Telemedycyna Polska SA
WSE:TMP

TMP Competitors Multiples
Telemedycyna Polska SA Competitors